Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013-2017: Findings from a population-based observational study
- PMID: 35243321
- PMCID: PMC8867126
- DOI: 10.1016/j.jvacx.2022.100145
Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013-2017: Findings from a population-based observational study
Abstract
Introduction: Although vaccines provide a cost-effective solution to vaccine-preventable diseases (VPDs), the disease burden of VPDs is still very high in most parts of the world.
Methods: A population-based observational study was conducted in Shandong province, China, from 2013 to 2017, giving an insight into the epidemiological characteristics and disease burden of seven VPDs. The incidence trend was estimated using the Poisson regression model. The disease burden was calculated using the disability-adjusted life years (DALYs).
Results: Most VPDs included in the China's National Immunization Program had higher incidence density (ID) in inland cities. The ID of mumps decreased significantly, while herpes zoster increased (both P < 0.05). The top three causes of the disease burden as assessed with DALYs included tuberculosis, herpes zoster, and hepatitis B, with the rates of 72.21, 59.99, and 52.10 DALYs/100 000, respectively. The disease burden of influenza and herpes zoster were relatively high in people aged > 50 years, while highest DALYs of hepatitis B were found in young adults.
Conclusion: Inequalities in the vaccine coverage by geography, socio-economic status, and targeted population contribute to the increasing incidence and high burden of VPDs and call for renewed and sustained immunization strategies in China.
Keywords: China; Disease burden; Epidemiological characteristics; Incidence trend; Vaccine-preventable diseases.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Global, regional, and national burdens of vaccine-preventable infectious diseases with high incidence among middle-aged and older adults aged 55-89 years from 1990 to 2021: Results from the global burden of disease study 2021.Vaccine. 2025 Mar 7;49:126786. doi: 10.1016/j.vaccine.2025.126786. Epub 2025 Jan 30. Vaccine. 2025. PMID: 39889537
-
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain.BMC Infect Dis. 2024 Aug 5;24(1):779. doi: 10.1186/s12879-024-09637-x. BMC Infect Dis. 2024. PMID: 39103777 Free PMC article.
-
The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic.J Infect Chemother. 2021 Oct;27(10):1482-1488. doi: 10.1016/j.jiac.2021.06.021. Epub 2021 Jul 5. J Infect Chemother. 2021. PMID: 34244054 Free PMC article.
-
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective.Hum Vaccin Immunother. 2023 Aug 1;19(2):2224186. doi: 10.1080/21645515.2023.2224186. Hum Vaccin Immunother. 2023. PMID: 37402477 Free PMC article. Review.
-
Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.Hum Vaccin Immunother. 2022 Dec 31;18(1):1939620. doi: 10.1080/21645515.2021.1939620. Epub 2021 Jul 1. Hum Vaccin Immunother. 2022. PMID: 34197271 Free PMC article. Review.
Cited by
-
Urban-rural disparities in the association of nitrogen dioxide exposure with cardiovascular disease risk in China: effect size and economic burden.Int J Equity Health. 2024 Feb 6;23(1):22. doi: 10.1186/s12939-024-02117-3. Int J Equity Health. 2024. PMID: 38321458 Free PMC article.
-
Long-term exposure to particulate air pollution associated with the progression of type 2 diabetes mellitus in China: effect size and urban-rural disparities.BMC Public Health. 2025 Apr 26;25(1):1565. doi: 10.1186/s12889-025-22394-z. BMC Public Health. 2025. PMID: 40287677 Free PMC article.
-
Preferences and Willingness to Pay for Herpes Zoster Vaccination Among Chinese Adults: Discrete Choice Experiment.JMIR Public Health Surveill. 2024 Aug 9;10:e51242. doi: 10.2196/51242. JMIR Public Health Surveill. 2024. PMID: 39121469 Free PMC article.
-
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20. Hum Vaccin Immunother. 2024. PMID: 38767209 Free PMC article.
-
Challenges in the Vaccination of the Elderly and Strategies for Improvement.Pathophysiology. 2023 Apr 22;30(2):155-173. doi: 10.3390/pathophysiology30020014. Pathophysiology. 2023. PMID: 37218912 Free PMC article. Review.
References
-
- WHO . Global Vaccine Action Plan 2011–2020. World Health Organization; Geneva, Switzerland: 2013.
LinkOut - more resources
Full Text Sources
Miscellaneous